Insights

Quantum collaboration SCREEN Group is actively developing high-speed optical modules for neutral-atom quantum processors and has partnered with Yaqumo on NEDO projects. This presents a sales opportunity to offer advanced optical components, precision optics, and integration support for quantum computing applications.

Semiconductor growth Recent announcements show SCREEN expanding R&D infrastructure in New York and strengthening ties with major players like Applied Materials and IBM for semiconductor cleaning and process stability. A viable upside for sales teams is offering advanced surface processing and cleaning solutions, as well as collaborative equipment and service packages.

Revenue optimization Despite mixed sales, SCREEN posted notable revenue and profitability figures, signaling resilience. This environment favors partnerships around high-efficiency production platforms, inkjet digital press certifications, and scalable process modules that improve yield and reduce unit costs.

Life sciences leverage Screen’s high-speed 3D cell culture scanner and morphology analysis system use proprietary image processing to enable reagent-free cell analysis, aiding cancer drug development and regenerative medicine. There is an opportunity to cross-sell imaging analytics software, consumables, and integration services to biotech and pharma R&D teams.

Global expansion With a global footprint, surface processing and image processing technologies, and partnerships across regions, SCREEN is positioned to offer turnkey solutions combining hardware, software, and services for display, semiconductor, and research institutions seeking scalable, high-performance solutions.

Similar companies to SCREEN Biosciences

SCREEN Biosciences Tech Stack

SCREEN Biosciences uses 8 technology products and services including Google Ads, Amazon Web Services, Squarespace, and more. Explore SCREEN Biosciences's tech stack below.

Media & News

SCREEN Biosciences's Email Address Formats

SCREEN Biosciences uses at least 5 email formats:
SCREEN Biosciences Email FormatsExamplePercentage
First.Last@dnse.comJohn.Doe@dnse.com
90%
FLast@dnse.comJDoe@dnse.com
9%
F.Last@dnse.comJ.Doe@dnse.com
1%
Last@screen.co.jpDoe@screen.co.jp
59%
F.Last@screen.co.jpJ.Doe@screen.co.jp
41%

Frequently Asked Questions

What is SCREEN Biosciences's official website and social media links?

Minus sign iconPlus sign icon
SCREEN Biosciences's official website is screen.co.jp and has social profiles on LinkedIn.

How much revenue does SCREEN Biosciences generate?

Minus sign iconPlus sign icon
As of August 2026, SCREEN Biosciences's annual revenue is estimated to be $1M - $10M.

What is SCREEN Biosciences's SIC code and NAICS code?

Minus sign iconPlus sign icon
SCREEN Biosciences's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does SCREEN Biosciences have currently?

Minus sign iconPlus sign icon
As of August 2026, SCREEN Biosciences has approximately 16 employees across 3 continents, including Asia, Africa and North America. Key team members include Department Manager: H. M. and Junior Accountant: F. C. Explore SCREEN Biosciences's employee directory with LeadIQ.

What industry does SCREEN Biosciences belong to?

Minus sign iconPlus sign icon
SCREEN Biosciences operates in the Biotechnology Research industry.

What technology does SCREEN Biosciences use?

Minus sign iconPlus sign icon
SCREEN Biosciences's tech stack includes Google Ads, Amazon Web Services, Squarespace, WordPress, Squarespace Commerce, Imperva, Miro and Piwik PRO Core.

What is SCREEN Biosciences's email format?

Minus sign iconPlus sign icon
SCREEN Biosciences's email format typically follows the pattern of First.Last@dnse.com. Find more SCREEN Biosciences email formats with LeadIQ.

When was SCREEN Biosciences founded?

Minus sign iconPlus sign icon
SCREEN Biosciences was founded in 1868.
SCREEN Biosciences logo

SCREEN Biosciences

Biotechnology ResearchKyoto, Japan11-50 Employees

SCREEN Biosciences operates within the biotechnology research sector and is part of the SCREEN Group, a long-standing Kyoto-based organization with origins tracing back to a lithographic printing shop established in 1868. The company focuses on life sciences applications, leveraging proprietary image processing technologies to support high-speed 3D cell culture scanning and cell morphology analysis, enabling rapid measurement and analysis of cellular growth and changes without the use of reagents. Its products address research needs in cancer drug development and regenerative medicine by providing tools to accelerate biomedical investigations, while the broader SCREEN Group continues to serve customers in printing, electronics, semiconductors, and displays through surface processing and image technologies. Based in Kyoto, the organization emphasizes research and development across its core technologies, expanding applications to foster new business opportunities. A recent development includes the SCREEN Group’s broader collaborations and facility expansions in areas related to semiconductor and digital printing solutions, reflecting ongoing efforts to strengthen its position in global markets. } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } }

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1868
Employees
11-50

Section iconFunding & Financials

  • $1M - $10M

    SCREEN Biosciences's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.